San Antonio Breast Cancer Symposium

Healio.com brings you the highlights from the San Antonio Breast Cancer Symposium. Refer back to this page often to read the latest news from SABCS, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Three researchers to be honored at San Antonio Breast Cancer Symposium

October 14, 2018
Three highly regarded researchers will be honored at this year’s San Antonio Breast Cancer Symposium, scheduled for Dec. 4-8. Ian
Meeting News

Researchers confirm axillary node dissection unnecessary for all node-positive breast cancers

December 22, 2017
SAN ANTONIO — The 10-year follow-up results of the IBCSG 23-01 trial confirmed that complete axillary node dissection may not be required for…
Meeting NewsPerspective

Weight loss reduces breast cancer risk for postmenopausal women

December 21, 2017
SAN ANTONIO — A 5% weight loss reduced risk for breast cancer among a large cohort of postmenopausal women, according to study results…
Meeting NewsPerspective

CDK4/6 inhibitors may benefit older patients with metastatic breast cancer

December 21, 2017
SAN ANTONIO — Patients with breast cancer aged 70 years or older tolerated treatment with CDK4/6 inhibitor therapy, according to results of a…
Meeting News

Risk score predicts recurrence risk in women with DCIS

December 19, 2017
SAN ANTONIO — A novel biological risk score improved the ability to predict recurrence risk among women with ductal carcinoma in situ who…
Meeting News

Preoperative endocrine therapy improves outcomes for certain women with DCIS

December 19, 2017
SAN ANTONIO — Six months of preoperative endocrine therapy appeared safe and effective among postmenopausal women with ER-positive ductal…
Meeting News

Larger margin width reduces local recurrence for early-stage breast cancer

December 19, 2017
SAN ANTONIO — Excision margins wider than “no tumor on ink” further decreased risk for local recurrence compared with narrower…
Meeting NewsPerspective

Pathologic complete response may be strong surrogate endpoint for breast cancer survival

December 14, 2017
SAN ANTONIO — Pathological complete response appeared to be a viable surrogate outcome for EFS and distant RFS, according to long-term efficacy…
Meeting NewsPerspective

Circulating tumor cells predict risk for late breast cancer recurrence

December 14, 2017
SAN ANTONIO — Circulating tumor cells showed clinical validity as a prognostic biomarker for late recurrence of hormone receptor-positive…
Meeting News

Talazoparib improves PFS over chemotherapy for patients with BRCA mutations

December 14, 2017
SAN ANTONIO — The PARP inhibitor talazoparib improved PFS over investigator’s choice chemotherapy among patients with advanced breast…

Meeting Calendar

San Antonio Breast Cancer Symposium

December 4, 2018 - December 8, 2018